Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Ulcerative Colitis Clinical Trials

101 recruiting trials for Ulcerative Colitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
101
Total Trials
101
Recruiting Now
7
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT04191395

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points....

Sponsor: Centre Hospitalier Universitaire de BesanconEnrolling: 30001 location
RECRUITINGPhase 2NCT04924270

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

PURPOSE: The main purpose is to explore clinical efficacy and safety associated with capsule FMT (cFMT) performed in newly diagnosed, untreated patients with rheumatic and...

Sponsor: Odense University HospitalEnrolling: 2001 location
RECRUITINGNCT06315179

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation...

Sponsor: Seattle Children's HospitalEnrolling: 2001 location
RECRUITINGNCT06094608

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Sponsor: University of MichiganEnrolling: 681 location
RECRUITINGNCT04178408

IBD Registry in a Sub-Saharan African Population

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will...

Sponsor: University of ZimbabweEnrolling: 1001 location
RECRUITINGNCT06042387

Genome Analysis Across Populations in Inflammatory Bowel Disease

Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

Sponsor: Mount Sinai Hospital, CanadaEnrolling: 1501 location
RECRUITINGPhase 1 / Phase 2NCT03847467

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF...

Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1163 locations
RECRUITINGNCT06550310

Nutrition and Clinical Outcomes in IBD

The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD). The...

Sponsor: Barts & The London NHS TrustEnrolling: 3001 location
RECRUITINGNCT05633706

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will...

Sponsor: Nimble Science Ltd.Enrolling: 3001 location
RECRUITINGNCT03809728

IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE

Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 10001 location
RECRUITINGNCT05230173

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of...

Sponsor: University of California, San DiegoEnrolling: 25020 locations
RECRUITINGNCT05733845

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD) represent a group of immune-mediated disorders, in which currently unidentified trigger factors drive the manifestation of chronic relapsing-...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 1001 location
RECRUITINGNCT04331639

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

The investigators will be administering oral high dose interval vitamin D, concurrently when participants are receiving biologic therapy for their inflammatory bowel disease. The...

Sponsor: Boston Children's HospitalEnrolling: 501 location
RECRUITINGNCT05698745

Immunological Characteristics of Preclinical IBD

The purpose of this study is to evaluate disease progression, in terms of development of symptomatic disease and complications associated with IBD (e.g. fistula, abscess,...

Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis UlcerosaEnrolling: 45020 locations
RECRUITINGPhase 3NCT06937086

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active...

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo,...

Sponsor: Eli Lilly and CompanyEnrolling: 35020 locations
RECRUITINGPhase 2NCT05574387

Metformin as Added on Therapy in Patients With Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is marked by increased intestinal motility and bloody diarrhea. The clinical value of existing therapeutic...

Sponsor: Tanta UniversityEnrolling: 461 location
RECRUITINGNCT07243639

Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis

Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course,...

Sponsor: Showa Inan General HospitalEnrolling: 301 location
RECRUITINGEarly Phase 1NCT05610956

Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis

•This study will be a randomized, controlled, parallel study. .To demonstrate the efficacy of empagliflozin and clinical improvement in patients of mild to moderate UC using the...

Sponsor: Tanta UniversityEnrolling: 601 location
RECRUITINGPhase 2NCT06975722

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Ulcerative Colitis. The primary objective of this study is to assess the efficacy of different doses...

Sponsor: SanofiEnrolling: 9920 locations
RECRUITINGPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative...

The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally...

Sponsor: Bristol-Myers SquibbEnrolling: 12020 locations
RECRUITINGNCT07224113

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

This study explores whether simple nutrition education can help children and teens with inflammatory bowel disease (IBD) eat fewer ultra-processed foods (UPFs). UPFs include...

Sponsor: Connecticut Children's Medical CenterEnrolling: 1201 location
RECRUITINGPhase 2NCT07427017

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Micronutrient deficiencies are common in ulcerative colitis (UC). Selenium deficiency is associated with worse disease outcomes including disease flares and need for surgery....

Sponsor: Northwestern UniversityEnrolling: 1801 location
RECRUITINGPhase 3NCT06588855

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in...

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in...

Sponsor: Hoffmann-La RocheEnrolling: 35020 locations
RECRUITINGNCT05739162

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

The purpose of this research is to gather information on the safety and effectiveness of Endoscopic Sleeve Gastroplasty (ESG) for weight loss in a population of obese UC patients...

Sponsor: Mayo ClinicEnrolling: 121 location
RECRUITINGPhase 2NCT06604260

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

Our main objective is to evaluate the feasibility of 68Ga-FAPi PET/CT in detecting intestinal fibrosis in patients with IBD. To this end, we will determine 68Ga-FAPi uptake in IBD...

Sponsor: Dalia LarteyEnrolling: 201 location
RECRUITINGNCT06065228

Therapeutic Endpoint in Pediatric IBD Conditions

The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically...

Sponsor: Children's National Research InstituteEnrolling: 601 location
RECRUITINGNCT06764706

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe...

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will...

Sponsor: AbbVieEnrolling: 20020 locations
RECRUITINGNCT07242248

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's...

The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the...

Sponsor: Janssen-Cilag Ltd.Enrolling: 2201 location
RECRUITINGNCT06862843

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic...

The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting...

Sponsor: Meyer Children's Hospital IRCCSEnrolling: 904 locations
RECRUITINGPhase 2NCT07229950

A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With...

This study is a randomized, double-blind, placebo-controlled Phase II clinical trial comprising screening period, treatment period, and follow-up period. This phase 2 study is...

Sponsor: Shandong Suncadia Medicine Co., Ltd.Enrolling: 661 location
RECRUITINGPhase 1 / Phase 2NCT06606808

Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Crohn\'s Disease (CD) and Ulcerative Colitis (UC) are chronic inflammatory bowel diseases (IBD). Risankizumab is a human monoclonal antibody against IL23 p19, part of a...

Sponsor: University Medical Center GroningenEnrolling: 181 location
RECRUITINGNCT06256393

Inflammatory Bowel Disease Cohort in Nantes

The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease

Sponsor: Nantes University HospitalEnrolling: 3603 locations
RECRUITINGNCT05456412

JAK Inhibition in Ulcerative Colitis

The treatment for Ulcerative Colitis (UC) aims to achieve and maintain remission and is usually lifelong and expensive. Current available medications are unable to break the cycle...

Sponsor: Leiden University Medical CenterEnrolling: 601 location
RECRUITINGNCT07046468

Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer

The goal of this observational pilot study with invasive measurements is to explore whether an ingestible sensor pill can be of use in diagnosis or monitoring of disease in...

Sponsor: Radboud University Medical CenterEnrolling: 101 location
RECRUITINGPhase 1NCT06627556

A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants

The primary purpose of this study is to evaluate the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy...

Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd.Enrolling: 641 location
RECRUITINGPhase 3NCT07184996

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely...

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with...

Sponsor: SanofiEnrolling: 98020 locations
RECRUITINGNCT07269223

Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients

This randomized controlled trial aims to evaluate the effect of oral vitamin D3 supplementation on inflammatory biomarkers and disease activity in Pakistani patients with moderate...

Sponsor: University of Veterinary and Animal Sciences, Lahore - PakistanEnrolling: 601 location
RECRUITINGNCT07011979

SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease

The goal of this observational study is to investigate characteristics of individuals at high risk for developing Inflammatory Bowel Disease (IBD) in order to identify risk...

Sponsor: Seoul National University HospitalEnrolling: 5001 location
RECRUITINGPhase 3NCT07158242

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to...

This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pediatric participants...

Sponsor: Hoffmann-La RocheEnrolling: 1004 locations
RECRUITINGNCT04030676

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoMegaloVirus (CMV)...

Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 1962 locations
RECRUITINGPhase 2NCT06421818

Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis

Baitouweng Decoction is traditionally used to treat large intestine damp-heat syndrome of ulcerative colitis (UC) by oral administration and rectal enema.The project applicant's...

Sponsor: The Second Hospital of Nanjing Medical UniversityEnrolling: 1441 location
RECRUITINGPhase 2NCT07064707

Rupatadine in Patients With Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory condition that primarily targets the large intestine. Although substantial progress has been made in treatment...

Sponsor: Alexandria UniversityEnrolling: 601 location
RECRUITINGNCT06498167

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

The LOOK-UP is an investigator-initiated clinical study with the aim of monitoring the post-marketing safety of the medicine Rinvoq™ (upadacitinib), which is indicated for the...

Sponsor: Universidade do PortoEnrolling: 1503 locations
RECRUITINGPhase 2NCT07333716

Desloratadine in Patients With Ulcerative Colitis

The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant...

Sponsor: Tanta UniversityEnrolling: 441 location
RECRUITINGPhase 3NCT03221036

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

The purpose of this study is to assess the effect of vedolizumab intravenous IV as induction and maintenance treatment in Chinese participants with moderately to severely active...

Sponsor: TakedaEnrolling: 40220 locations
RECRUITINGNCT05186623

Prediction Model for Response to Biologics and Small Molecular Agent for UC

This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with...

Sponsor: Asan Medical CenterEnrolling: 3001 location
RECRUITINGNCT06571669

BOOM-IBD2 Pivotal Clinical Trial

The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.

Sponsor: Boomerang MedicalEnrolling: 13710 locations
RECRUITINGNCT04121806

Diet Intervention Treatment for Active Ulcerative Colitis

The purpose of this study is to determine if a sustainable non-elemental diet can be used as a probiotic tool to alter the dysbiotic microbiome found in individuals with...

Sponsor: Mount Sinai Hospital, CanadaEnrolling: 201 location
RECRUITINGPhase 4NCT07303686

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

The goal of this clinical trial is to evaluate whether disease remission can be maintained when biologic therapy is reduced in patients with Crohn"s disease (CD) and ulcerative...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 1151 location

Showing 50 of 101 trials.Search all Ulcerative Colitis trials